CurrentEndo
Get Weekly

Topic · page 5 of 12

Lipids & metabolic liver disease

Lipid disorders and metabolic dysfunction-associated steatotic (fatty) liver disease, as published in the endocrine journals

Briefs 161–200 of 460 placed here, newest publication first

Briefs in Lipids & metabolic liver disease

Newest publication first

  1. Cardiovasc Diabetol

    Remnant–to–LDL cholesterol discordance as a predictor of thromboembolic events in anticoagulated patients with atrial fibrillation: a report from the prospective Murcia AF project III (MAFP-III) cohort study

    Cohort study

  2. Int J Obes (Lond)

    Modelling the direct and indirect associations between anthropometric and behavioural factors when predicting atherogenic risk index (TC/HDL-C) ratio

    Cross-sectional study

  3. Endocr Pract

    Characteristics of Dyslipidemia in Adults With Resistance to Thyroid Hormone β

    Cross-sectional study

  4. Pediatr Obes

    Metabolic Dysfunction‐Associated Steatotic Liver Disease in an Urban Paediatric Cohort With High Socioeconomic Deprivation

    Cohort study

  5. Cardiovasc Diabetol

    Interpretable machine learning analysis of immunoinflammatory biomarkers for predicting CHD among NAFLD patients

    Cohort study

  6. Diabetologia

    Steatotic liver disease interacts with a polygenic risk score for triglyceride clearance to impact the risk of hypertriglyceridaemia: The Maastricht Study

    Cross-sectional study

  7. Diabetes Obes Metab

    Metabolic dysfunction‐associated steatotic liver disease and sex‐specific risk of fatal and non‐fatal cardiovascular events: A meta‐analysis

    Meta-analysis

  8. Diabetes Metab

    The impact of chiglitazar, a pan-PPAR agonist, on metabolic dysfunction-associated steatotic liver disease in patients with type 2 diabetes: a real-world study

    Cohort study

  9. Diabetes Res Clin Pract

    Hepatic steatosis with significant fibrosis is associated with preclinical carotid atherosclerosis in patients with type 1 diabetes

    Cross-sectional study

  10. J Clin Endocrinol Metab

    Metabolic Dysfunction-associated Steatotic Liver Disease Alters Fatty Acid Profiles in the Liver and Adipose Tissue

    Cross-sectional study

  11. Diabetes Obes Metab

    A plasma metabolome‐derived model predicts severe liver outcomes of nonalcoholic fatty liver disease in the UK Biobank

    Diagnostic or prognostic study

  12. J Clin Endocrinol Metab

    The Relationships Between MASLD, Extrahepatic Multimorbidity, and All-Cause Mortality in the UK Biobank Cohort

    Cohort study

  13. J Clin Endocrinol Metab

    Efficacy of GLP-1-based Therapies on Metabolic Dysfunction-associated Steatotic Liver Disease and Metabolic Dysfunction-associated Steatohepatitis: A Systematic Review and Meta-analysis

    Meta-analysis

  14. Diabetes Obes Metab

    Management of metabolic dysfunction–associated steatotic liver disease ( MASLD )—An expert consensus statement from Indian diabetologists' perspective

    Guideline or statement

  15. Diabetes Res Clin Pract

    Hepatic steatosis is associated with impaired hepatic glucose uptake under hyperglycemic conditions, a dynamic whole-body 18F-FDG PET approach

    Cross-sectional study

  16. Diabetes Care

    Metabolic Dysfunction–Associated Steatotic Liver Disease (MASLD) in People With Diabetes: The Need for Screening and Early Intervention. A Consensus Report of the American Diabetes Association

    Guideline or statement

  17. Endocr Pract

    Diagnosis Frequency and Associated Factors of Nonalcoholic Fatty Liver Disease Among United States Hospitalized Adults in Urban vs Rural Populations From 2007 to 2019: An Emerging Public Health Crisis

    Cross-sectional study

  18. Cardiovasc Diabetol

    Association between the atherogenic index of plasma and incident hypertension across different blood pressure states: a national cohort study

    Cohort study

  19. Eur J Endocrinol

    Proteomic variation underlies the heterogeneous risk of metabolic dysfunction-associated steatotic liver disease for subsequent chronic diseases

    Cohort study

  20. Diabetes Obes Metab

    Antidiabetic and lipid‐lowering medication use inversely linked with serum biomarkers of liver fibrosis

    Cross-sectional study

  21. J Clin Endocrinol Metab

    Dyslipidemia Is Associated With Increased Natural Killer Cell Cytotoxicity and Autoimmunity in Women With Recurrent Pregnancy Losses

    Cross-sectional study

  22. Cardiovasc Diabetol

    Atherogenic lipid parameters in people with normal glucose tolerance: implications from elevated 1-hour post-load plasma glucose

    Cross-sectional study

  23. Cardiovasc Diabetol

    The association between different insulin resistance surrogates and all-cause mortality and cardiovascular mortality in patients with metabolic dysfunction-associated steatotic liver disease

    Cohort study

  24. J Clin Endocrinol Metab

    Associations of Sleep Health and Metabolic Syndrome Severity in Black Individuals: The Jackson Heart Sleep Study

    Cross-sectional study

  25. Endocr Pract

    Diagnostic Performance of Noninvasive Tests for Identifying Advanced Fibrosis in Metabolic Dysfunction-Associated Fatty Liver Disease With Mixed Etiologies

    Diagnostic or prognostic study

  26. Diabetes Res Clin Pract

    Impact of physical activities in metabolic dysfunction associated steatotic liver disease, sarcopenia, and cardiovascular disease

    Cross-sectional study

  27. Cardiovasc Diabetol

    Dyslipidemia and aging: the non-linear association between atherogenic index of plasma (AIP) and aging acceleration

    Cross-sectional study

  28. BMJ Open Diabetes Res Care

    AI-enabled opportunistic measurement of liver steatosis in coronary artery calcium scans predicts cardiovascular events and all-cause mortality: an AI-CVD study within the Multi-Ethnic Study of Atherosclerosis (MESA)

    Cohort study

  29. Diabetes Obes Metab

    Comparative efficacy and safety of pharmacologic therapies for metabolic dysfunction‐associated steatotic liver disease over 24 weeks in reducing liver steatosis and fibrosis: A network meta‐analysis

    Meta-analysis

  30. Cardiovasc Diabetol

    Associations between cardiometabolic indices and the onset of metabolic dysfunction-associated steatotic liver disease as well as its progression to liver fibrosis: a cohort study

    Cohort study

  31. Diabetes Obes Metab

    Characterization of brain morphology associated with metabolic dysfunction‐associated steatotic liver disease in the UK Biobank

    Cross-sectional study

  32. J Clin Endocrinol Metab

    Non-Esterified Fatty Acid Profiles and Cause-Specific Mortality: The Cardiovascular Health Study

    Cohort study

  33. Diabetes Obes Metab

    Comprehensive evaluation of siRNA therapeutics on Lp(a): A network meta‐analysis

    Meta-analysis

  34. Cardiovasc Diabetol

    Evaluation of glycemic status and subclinical atherosclerosis in familial hypercholesterolemia subjects with or without LDL receptor mutation

    Cross-sectional study

  35. Eur J Endocrinol

    Metabolic syndrome in childhood, adolescent, and young adult cancer survivors: recommendations for surveillance from the International Late Effects of Childhood Cancer Guideline Harmonization Group

    Guideline or statement

  36. J Clin Endocrinol Metab

    Triglyceride–Glucose Index and Risks of All-Cause and Cause-Specific Mortality in Young Adults

    Cohort study

  37. Diabetes Res Clin Pract

    HOMA-IR and TyG index differ for their relationship with dietary, anthropometric, inflammatory factors and capacity to predict cardiovascular risk

    Cross-sectional study

  38. Diabetes Metab

    Acute kidney injury is associated with liver-related events in patients with metabolic dysfunction-associated fatty liver disease

    Cohort study

  39. Diabetes Metab

    Persistent gaps in the implementation of lipid-lowering therapy in patients with established atherosclerotic cardiovascular disease: A French nationwide study

    Cross-sectional study

  40. Diabetes Obes Metab

    Associations of intra‐pancreatic fat deposition with triglyceride‐rich lipoproteins and lipoprotein lipase

    Cross-sectional study

All 460 Briefs in ExploreShowing Briefs 161–200 of 460, newest first